Treatment with cotrimoxazole in infants exposed to HIV but uninfected (HEU) increases resistance gene prevalence and α-diversity and decreases microbial taxonomic, functional pathway, and resistance gene β-diversity.
Researchers found that in patients with hepatitis B virus there are differences in patients with fatty liver and nonalcoholic fatty liver disease, which can be accurately quantified with second-harmonic generation and 2-photon excited fluorescence.
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Researchers found data that showed the modulation of miR-211-5p and NR1I3, long noncoding RNAs work to regulate the progression of hepatitis B virus-related hepatocellular carcinoma by interfering with the cellular physiology.
A substantial number of HIV infections are likely attributable to pre-existing infection with the herpes simplex virus type 2.
Researchers evaluated the microbial characteristics driving ankylosing spondylitis pathogenesis, and they examined the effects of tumor necrosis factor inhibitor therapy on the microbiome.
A new vaccine for the avian influenza A(H5N1) was shown to be safe and immunogenic.
Investigators found data that showed in patients with compensated cirrhosis and chronic HCV genotypes 1 to 6 who were treatment-naive, the once-daily, oral, fixed-dose combination of glecaprevir/pibrentasvir taken for 8 weeks had high SVR12 rates.
The Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) have updated consensus definitions of invasive fungal diseases.
Researchers found data that showed hepatitis B virus DNA replication was suppressed, and liver inflammation was improved in patients with chronic hepatitis B, during oral antiviral therapy.
